Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Biote (BTMD) EBT (2021 - 2025)

Biote (BTMD) has 3 years of EBT data on record, last reported at $5.6 million in Q4 2023.

  • For Q4 2023, EBT rose 111.79% year-over-year to $5.6 million; the TTM value through Dec 2023 reached -$4.0 million, up 96.81%, while the annual FY2024 figure was -$308000.0, 27.19% up from the prior year.
  • EBT reached $5.6 million in Q4 2023 per BTMD's latest filing, down from $6.1 million in the prior quarter.
  • Across five years, EBT topped out at $15.1 million in Q4 2021 and bottomed at -$86.4 million in Q2 2022.
  • Average EBT over 3 years is -$7.9 million, with a median of $5.4 million recorded in 2023.
  • The widest YoY moves for EBT: up 8817.5% in 2022, down 978.11% in 2022.
  • A 3-year view of EBT shows it stood at $15.1 million in 2021, then tumbled by 418.3% to -$47.9 million in 2022, then skyrocketed by 111.79% to $5.6 million in 2023.
  • Per Business Quant database, its latest 3 readings for EBT were $5.6 million in Q4 2023, $6.1 million in Q3 2023, and $5.1 million in Q2 2023.